DBVT · DBV Technologies ADR
United States · RS rating 6 · As of 2026-10-14
| Price | 8.87 USD |
|---|---|
| 1-day change | -1.8% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 9 / 7 / 15 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 4 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -9.1% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +63.9% |
| Market cap (USD) | $1.1B |